04 Feb Plan to lower drug costs may actually hurt U.S. legacy of innovation
Joseph P. Allen
Seattle Times, 2/4/2024...
News
28 Jan The Bayh-Dole Act works. It’s not time to change it.
Jon Soderstrom
Hartford Courant, 1/28/2024...
25 Jan Nobel prizes, cancer drugs and $280 million just part of Carol Mimura’s UC Berkeley legacy
Ron Leuty
San Francisco Business Times, 1/25/2024...
24 Jan Don’t punish small business heroes behind pandemic response
Jennifer C. Cheng
The Mercury News, 1/24/24
Also published in the East Bay Times and the Greeley Tribune...
23 Jan Protect Future Discoveries By Rejecting The TRIPS Patent Waiver
Lindsay Androski
International Business Times, 1/23/24...
22 Jan In ‘march-in’ rights, some see a tool to lower drug prices. Others see a threat to intellectual property
Ed Silverman
STAT, 1/22/24...
18 Jan Don’t let geopolitics erode America’s research engine
Erik Iverson
The Cap Times, 1/18/24...
18 Jan Bayh-Dole Champions to NIST: Biden’s March-In Proposal Must ‘Immediately Be Withdrawn’
Eileen McDermott
IPWatchdog, 1/18/24
...
17 Jan Voters Strongly Oppose Weakening Patents, New Poll Shows
WASHINGTON, D.C. (January 17, 2024) -- The Biden administration may soon endorse a proposal before the World Trade Organization (WTO) that would suspend patent protections on Covid-19 treatments and tests and, in doing so, thwart existing WTO standards. This move would be enormously unpopular with American voters, according to a new poll released today by the Bayh-Dole Coalition....
10 Jan Rogue Bureaucrats Want to Corrupt the Bayh-Dole Act
Dave Allen
WSYR-AM, 1/10/24...